logistic regression analysis

Related by string. Logistic regression analysis * LOGISTICS . logistics . Logistics : Logistics Readiness Squadron . Quiet Logistics . Sunoco Logistics Partners LP / Regression . regressions : linear regression . multivariate logistic regression . multivariate regression analysis / analy sis . ANALYSIS . Analysis : Chart Analysis News . Strategic Analysis Review . Electronic Document Analysis * *

Related by context. All words. (Click for frequent words.) 79 logistic regression model 79 conditional logistic regression 78 Logistic regression 77 multiple logistic regression 77 logistic regression 77 multivariate analyzes 77 logistic regression analyzes 77 logistic regression models 77 multivariate logistic regression 77 univariate 75 Multivariate analysis 75 multivariable analysis 74 multivariate Cox 74 univariate analyzes 74 multiple linear regression 73 odds ratios ORs 73 multivariable logistic regression 73 covariate 73 bivariate 73 Logistic regression analysis 72 stepwise logistic regression 72 Univariate analysis 72 confidence intervals CIs 72 Poisson regression 71 Multiple logistic regression 71 binary logistic regression 71 Kaplan Meier analysis 71 Multivariate logistic regression 70 Univariate 70 Multiple linear regression 70 univariate analysis 70 multivariate analysis 70 MDRD 70 multivariable Cox 69 covariates 69 ANOVA 69 estimated GFR 68 multivariate regression analysis 68 multivariable adjusted 68 intraobserver 68 Mantel Haenszel 68 retrospective cohort 68 allele frequencies 68 Bonferroni correction 68 meta regression 68 logistic regressions 68 Subgroup analysis 67 preoperative PSA 67 linear regression analyzes 67 generalized estimating 67 clinicopathological 67 angiographically 67 Pearson correlation coefficients 67 HOMA IR 67 APOE genotype 67 nonparametric 67 bivariate analyzes 67 euthymic patients 67 multivariate regression 67 Descriptive statistics 67 regression analyzes 67 intima media thickness 66 Linear regression 66 interobserver reliability 66 Kaplan Meier method 66 Subgroup analyzes 66 interobserver 66 variance ANOVA 66 sociodemographic factors 66 Rating Scale BPRS 66 explanatory variables 66 prostate cancer CaP 66 bivariate analysis 66 symptomatic VTE 66 Pearson correlation coefficient 66 clinico pathological 66 histological subtype 66 familial aggregation 66 Kruskal Wallis test 66 LV dysfunction 65 intact parathyroid hormone 65 recursive partitioning 65 ANCOVA 65 differential gene expression 65 tumor histology 65 DAS# CRP 65 Multivariate analyzes 65 pretest probability 65 immunohistochemical 65 ROC curves 65 Glomerular filtration rate 65 nomogram 65 biochemical recurrence 65 IPAH 65 comorbidity 65 rs# [004] 65 chi squared 65 % CI #.#-#.# [007] 65 metabolite concentrations 65 multivariable analyzes 65 Brief Psychiatric 64 MTT assay 64 coronary stenosis 64 MMSE score 64 adenoma recurrence 64 endometrial thickness 64 sociodemographic characteristics 64 covariance 64 Kaplan Meier curves 64 mammographic density 64 generalized linear 64 premorbid 64 sleeve lobectomy 64 Preoperatively 64 MetS 64 BMI z 64 proportional hazards 64 spirometric 64 colorectal adenoma 64 CORE OM 64 % CI #.#-#.# [006] 64 electrophysiologic 64 EQ 5D 64 immunohistochemical staining 64 glomerular filtration 64 NIH CPSI 64 MDRD equation 64 covariance ANCOVA 64 interrater reliability 64 % CI #.#-#.# [003] 64 proband 64 depressive symptomatology 64 estimated glomerular filtration 64 seropositivity 64 pT2 64 periprocedural 64 genotypic resistance 64 prospective multicenter study 64 confounder 63 Regression analyzes 63 NIHSS 63 postoperative complication 63 regression coefficient 63 NIHSS score 63 linear regression analysis 63 advanced neoplasia 63 confidence interval CI 63 sociodemographic variables 63 diabetes mellitus DM 63 lymph node metastasis 63 ELBW infants 63 CYP#D# genotype 63 etiologic 63 APACHE II 63 confidence interval #.#-#.# 63 pCR 63 β blockers 63 immunoblotting 63 NHANES III 63 FEV ^ sub 63 Depressive symptoms 63 SNP rs# [002] 63 semiquantitative 63 ABCB1 63 somatoform disorders 63 CHADS2 63 PCa 63 FDG-PET/CT 63 Visual Analogue Scale VAS 63 nodal metastasis 63 AST ALT 63 % CI #.#-#.# [008] 63 hematopoietic cancers 63 convergent validity 63 Cardiorespiratory fitness 63 TT genotype 63 adiponectin concentrations 63 QTc prolongation 63 ASCUS 63 chronicity 63 oncologic outcomes 63 carotid IMT 63 nodal metastases 63 abdominal adiposity 63 prognostic variables 63 HRCT 63 HER2 overexpression 63 CSF biomarkers 63 Kaplan Meier survival 63 Neuropsychiatric Inventory NPI 63 RECIST Response Evaluation Criteria 62 EuroSCORE 62 urolithiasis 62 Kaplan Meier 62 p = .# [002] 62 noncardiac 62 creatinine clearance 62 autonomic dysfunction 62 multivariable 62 F FDG PET 62 susceptibility loci 62 cortical activation 62 chest radiographs 62 gadolinium enhanced 62 histologic subtype 62 Non inferiority 62 node metastases 62 transvaginal sonography 62 MADRS score 62 CC genotype 62 FDG PET imaging 62 SLNB 62 observational cohort study 62 Carotid Revascularization Endarterectomy vs. 62 meta analytic 62 familial clustering 62 transabdominal 62 ventricular myocardium 62 Bonferroni 62 definite stent thrombosis 62 interquartile range 62 QIDS SR 62 mL/min/#.# m 2 62 adenotonsillectomy 62 ROC curve 62 tertiles 62 prostate carcinoma 62 RT PCR assay 62 linear regressions 62 microalbumin 62 hallux valgus 62 Main Outcome Measures 62 SUVmax 62 endometrial carcinoma 62 nonobese patients 62 Multivariable 62 -#.# ± [002] 62 postintervention 62 prognostic factors 62 neurodevelopmental impairment 62 psychiatric comorbidities 62 CI -#.# 62 prospective longitudinal 62 Logistic regression analyzes 62 retrospective observational study 62 bone scintigraphy 62 nomograms 62 Reynolds Risk Score 62 transcranial Doppler 62 sociodemographic 62 subclinical atherosclerosis 62 nonfatal MI 62 Index CDAI 62 cTnI 62 randomized controlled trials RCTs 62 carotid intima media 62 Charlson comorbidity index 62 dyssynchrony 62 leukocyte counts 62 VKORC1 62 metaanalysis 62 histopathologic 62 Multivariable logistic regression 62 FDG uptake 62 sonographically 62 K ras mutations 62 histopathologic diagnosis 62 osteopenic 62 histopathologic findings 62 serum PSA 62 = #.#-#.# 62 #F FDG PET 62 femoral neck BMD 62 liver transplant recipients 62 albumin excretion rate 62 plasma cortisol 62 categorical variables 62 clinicopathological features 62 subgroup analyzes 62 polygenic 62 retrospective cohort study 61 gastric cardia 61 recurrent venous thromboembolism 61 prospectively defined 61 unpaired t 61 rs# [002] 61 antibody titer 61 ultrasonographic 61 genetic polymorphisms 61 transcranial Doppler ultrasound 61 morphometric vertebral fractures 61 allelic 61 radiographic findings 61 scintigraphic 61 Cardiopulmonary bypass 61 longitudinal cohort study 61 albumin excretion 61 Symptom severity 61 nonoperative treatment 61 locoregional recurrence 61 differentially expressed genes 61 mild renal impairment 61 glomerular filtration rate 61 CIN2 + 61 urodynamic 61 aortic calcification 61 gene polymorphisms 61 carotid plaques 61 metaplasia 61 #q# deletion syndrome 61 Cockcroft Gault 61 preoperatively 61 Logistic regression models 61 stratifying patients 61 serum urate levels 61 Montgomery Åsberg Depression 61 pelvic lymphadenectomy 61 HIV tropism 61 laterality 61 Experimentally 61 #OHD 61 thyroglobulin 61 hip BMD 61 immunohistochemical analysis 61 residual confounding 61 nonpsychotic 61 lymphadenectomy 61 Treatment Outcome 61 IL#B 61 serum concentrations 61 sonographically guided 61 Heritability 61 pT3 61 P = .# 61 carotid stenosis 61 prostate cancer PCa 61 myocardial viability 61 NMIBC 61 cardioembolic stroke 61 T2DM 61 histologically 61 actigraphy 61 serum estradiol 61 immunostaining 61 mRNA expression 61 DAS# scores 61 acetabular fractures 61 adnexal mass 61 primary aldosteronism 61 intraventricular hemorrhage 61 prognostic indicators 61 nondiabetic patients 61 rCBF 61 eNO 61 Hb A1C 61 heterozygotes 61 Response Evaluation Criteria 61 Postoperative complications 61 Multivariate 61 leukocyte count 61 FDG PET 61 DAS# [002] 61 Insulin sensitivity 61 TCF#L# gene 61 multivariate adjustment 61 liver histology 61 TRUS 61 tertile 61 adenoidectomy 61 comorbid anxiety 61 hierarchical clustering 61 cerebral microbleeds 61 comorbid depression 61 Randomized trials 61 surrogate markers 61 serum cortisol 61 carotid artery thickness 61 advanced adenomas 61 RARP 61 obstructive coronary artery 61 waist circumference WC 61 WOMAC pain 61 baseline FEV 61 p = #.# [003] 61 baseline LDH 61 RRM1 61 cytologic 61 sd = 61 F FDG uptake 61 transient elastography 61 posttreatment 61 hematological relapse 61 EUS FNA 61 transgene expression 61 QTcF 61 attain statistical significance 61 anthropometric measures 61 RE LY ® 61 microsatellite instability 61 recurrent VTE 61 PSA nadir 61 periprocedural MI 61 Charlson Comorbidity Index 61 airway hyperresponsiveness 61 Doppler sonography 60 genetic loci 60 PSADT 60 cranial irradiation 60 intraclass correlation coefficients 60 glycated hemoglobin levels 60 alexithymia 60 Crohn Disease Activity 60 airway responsiveness 60 Comorbidity 60 clinicopathologic 60 neurocognitive function 60 oral anticoagulation 60 nonobese 60 hip resurfacing arthroplasty 60 confounders 60 prospectively randomized 60 RNFL thickness 60 thrombophilia 60 TOP2A 60 HER2 expression 60 parasitaemia 60 atherothrombotic 60 D dimer 60 kidney allograft 60 conventional DMARDs 60 genotypic 60 OGTT 60 Kaplan Meier curve 60 plasma pharmacokinetics 60 subtrochanteric 60 Histologic 60 COMT genotype 60 sensitivity specificity 60 SNP rs# [001] 60 BEXXAR Therapeutic Regimen 60 inhibin B 60 lowest tertile 60 creatinine ratio 60 pairwise comparisons 60 extracapsular extension 60 glycated hemoglobin HbA1c 60 Sprague Dawley rats 60 doxorubicin docetaxel 60 pulmonary arterial 60 anthropometric measurements 60 nonfasting triglyceride levels 60 BMD measurements 60 Immunohistochemical analysis 60 concomitant medications 60 atheroma volume 60 X chromosome inactivation 60 histopathologic examination 60 ADRB2 60 perioperative morbidity 60 Main Outcome Measure 60 FDG PET scans 60 CTEPH 60 RE LY trial 60 plasma creatinine 60 chemoradiotherapy 60 Solid Tumors RECIST 60 eosinophil count 60 radical nephrectomy 60 HRQL 60 ECLS 60 neoadjuvant chemotherapy 60 CYP#D# inhibitor 60 dose proportionality 60 locoregional 60 confounding variables 60 overnight polysomnography 60 serum lactate 60 coronary calcification 60 ImmuKnow assay 60 echocardiographic parameters 60 comorbidities 60 S. maltophilia 60 postprocedure 60 breast carcinoma 60 probands 60 2D 4D ratio 60 specific antigen PSA 60 CI = 60 nonpharmacologic 60 femoral neck fracture 60 TNM staging 60 Child Behavior Checklist 60 comorbid disorders 60 rs# [001] 60 nonoperative 60 androgen suppression 60 NNRTI resistance 60 bronchoalveolar lavage 60 lymphocyte count 60 Wilcoxon rank sum 60 postoperative pulmonary 60 basal bolus regimen 60 PCWP 60 core needle biopsies 60 affective psychosis 60 percutaneous vertebroplasty 60 XIENCE V PROMUS Stent 60 % Confidence Interval 60 hemodynamic variables 60 Thrombolysis 60 biochemical relapse 60 electroencephalographic 60 Doppler echocardiography 60 induced sputum 60 intraventricular 60 thyrotropin levels 60 haplotypes 60 metabolic parameters 60 NHAMCS 60 ADAS cog 60 tipranavir r 60 posttransplant 60 extrapyramidal symptoms 60 serum BDNF 60 distal radial fractures 60 Cystatin C 60 tHcy 60 renal cysts 60 antral 60 octreotide LAR 60 cryptogenic 60 dosimetric 60 ischemic lesions 60 urothelial carcinoma 60 SCr 60 pancreatic adenocarcinoma 60 platelet reactivity 60 extracolonic findings 60 Echocardiographic 60 antiretroviral naïve 60 Fibromyalgia Impact Questionnaire 60 histopathological 60 correlation coefficients 60 recessive inheritance 60 thyroid carcinoma 60 Postoperative 60 variant allele 60 nonvertebral fracture 60 Suicidal ideation 60 linkage disequilibrium 60 antioxidant supplementation 60 timepoints 60 suicide attempters 60 T2D 60 clomipramine 60 comorbid conditions 59 perioperative mortality 59 thromboembolism 59 duplex ultrasonography 59 atypical hyperplasia 59 baseline HbA1c 59 interquartile range IQR 59 nulliparous women 59 poststroke 59 relapsed MM 59 Genotypic 59 CR nPR 59 radical prostatectomy RP 59 SLN biopsy 59 left ventricular diastolic 59 MDCT angiography 59 serum leptin 59 statistically significant p = 59 nondiabetic 59 postoperative infections 59 Score TOS 59 CIN3 59 hypercalciuria 59 syngeneic 59 liver metastasis 59 C#BL/#J mice 59 genomewide 59 Cardiotoxicity 59 somatostatin analog 59 arteriolar 59 serum bilirubin 59 extramedullary 59 dimensional echocardiography 59 VATS lobectomy 59 advanced adenoma 59 mammographically 59 subanalysis 59 prevalences 59 randomized blinded 59 operable breast cancer 59 haematologic 59 thromboembolic complications 59 apolipoprotein B 59 methacholine challenge 59 multivariable regression 59 FDG PET CT 59 potentially confounding variables 59 foveal thickness 59 Cytogenetic 59 CrCl 59 antithymocyte globulin 59 arterial thickening 59 mechanically ventilated patients 59 chemoradiation therapy 59 μmol L 59 corrected QT interval 59 overt hypothyroidism 59 LOCF 59 BENICAR HCT 59 CVD mortality 59 exhaled nitric oxide 59 % CI #.#-#.# [004] 59 lactate dehydrogenase LDH 59 seminal vesicle invasion 59 VNTR 59 APTIVUS r 59 clinically localized prostate 59 endoscopic ultrasonography 59 statistical significance p 59 multivariate adjusted 59 serum lipids 59 cytogenetic abnormalities 59 serum phosphorous 59 mucinous 59 proximal femur 59 transthoracic 59 karyotypes 59 transesophageal echocardiography 59 aortic root replacement 59 antidiabetic medication 59 potential confounders 59 Meta analyzes 59 System IPSS 59 thickness IMT 59 elevated LDH 59 Prognostic significance 59 visceral adiposity 59 TIMP 1 59 LVNC 59 χ 59 TURBT 59 perioperative complications 59 intima media thickness IMT 59 umbilical artery 59 efficacy evaluable 59 Interrater reliability 59 calcaneal fractures 59 liver biopsies 59 Immunohistochemical staining 59 prespecified secondary 59 prospective multicentre 59 invasive carcinomas 59 coinfected patients 59 NYHA functional class 59 paroxysmal AF 59 physiologic parameters 59 CP CPPS 59 NSTE ACS 59 pericardial effusion 59 prognostic significance 59 RECIST criteria 59 postdischarge 59 fasting insulin 59 K#N 59 cystatin C 59 biopsy Gleason 59 histologically proven 59 lactate dehydrogenase 59 LDL HDL 59 warfarin dosage 59 chorioamnionitis 59 #q# deletion 59 GnRH agonist 59 femoral shaft fracture 59 monozygotic 59 nonmelanoma skin cancers 59 cerebral angiography 59 Regression analysis 59 ertapenem 59 Serum creatinine 59 Legg Calvé Perthes disease 59 hypogonadotropic hypogonadism 59 Hypotension 59 hormone receptor status 59 hsCRP levels 59 T1a 59 unmeasured confounders 59 SSc 59 postoperative AF 59 urine cytology 59 Neuroticism 59 Computed tomography 59 serum albumin 59 nonmetastatic 59 pretransplant 59 fasting triglycerides 59 postoperative mortality 59 aneurysmal subarachnoid hemorrhage 59 overt nephropathy 59 Stenting Trial CREST 59 serum IGF 59 Adjuvant chemotherapy 59 axial length 59 flutamide 59 intravesical therapy 59 osteoid 59 rebleeding 59 nonpregnant women 59 cystectomy 59 inflammatory biomarkers 59 psychiatric comorbidity 59 genes differentially expressed 59 elevated CRP 59 tumor necrosis 59 somatization disorder 59 serous ovarian cancer 59 bronchial hyperresponsiveness 59 histologically confirmed 59 pressor response 59 hemodynamic parameters 59 coronary CTA 59 helical CT 59 Complications Trial 59 gadobutrol 59 transthoracic echocardiography 59 idraparinux 59 serum ferritin 59 empiric 59 Observational studies 59 carotid plaque 59 HIV RNA 59 CARDIA 59 IQR 59 esophageal carcinoma 59 BMI ≥ 59 serum triglycerides 59 psychiatric morbidity 59 Western blotting 59 macroalbuminuria 59 oral glucose tolerance 59 Severity MSCS score 59 contrast echocardiography 59 hyperinsulinemic euglycemic clamp 59 MMSE scores 59 eGFR 59 HRQoL 59 mean ± SEM 59 5 HTTLPR 59 apparent diffusion coefficient 59 rFSH 59 epithelial ovarian cancer 59 neuropsychological impairment 59 UPDRS 59 lymphovascular invasion 59 EDSS score 59 HbA 1c levels 59 ADAS Cog 59 impaired glucose metabolism 59 nondemented 59 hematologic toxicity 59 linear regression 59 colorectal neoplasia 59 postoperative delirium 59 methotrexate monotherapy 59 subscale scores 59 Aspergillus infections 59 adverse perinatal 59 thickness CIMT 59 variant rs# 59 hemodilution 59 thromboembolic events 59 subscore 59 biventricular repair 59 echocardiographic 59 YMRS 59 SerDes transceivers 59 mRS 59 lipid lowering agents 59 Ultrasonography 59 Primary endpoints 59 serum testosterone 59 patients undergoing CABG 59 ^ sup #m 59 pyridostigmine 59 coagulation parameters 59 Radical prostatectomy 59 androgen ablation 59 Tumor Response 59 HNSCC 59 statistically significant predictor 59 fractional anisotropy 58 GBA mutations 58 adrenalectomy 58 NAMCS 58 atherothrombotic disease 58 SSRI citalopram 58 subclinical hypothyroidism 58 MBq 58 CYP #D# 58 sulphonylureas 58 hyperplastic 58 hippocampal volume 58 unfractionated heparin UFH 58 hypertensives 58 glycosylated hemoglobin HbA1c 58 preterm neonates 58 underwent surgical resection 58 BI RADS 58 ALT elevation 58 atherogenic dyslipidemia 58 hamartomas 58 secondary efficacy endpoint 58 renal tumors 58 non valvular atrial 58 nonrandomized 58 familial AF 58 tipranavir ritonavir 58 potential confounding variables 58 HBeAg seroconversion 58 fasting plasma 58 salivary cortisol 58 Liver biopsy 58 microsatellite markers 58 syndromal 58 catechol O methyltransferase 58 CYP#D# gene 58 PERMP 58 psychiatric outpatients 58 pulmonary dysfunction 58 troponins 58 morphometric 58 BRCA2 mutation carriers 58 infarcts 58 GSTP1 58 abacavir lamivudine 58 homozygote 58 superior mesenteric artery 58 UKPDS 58 apo B 58 psychosocial variables 58 MR spectroscopy 58 demographic variables 58 plain radiographs 58 haemodynamic 58 depressive symptom 58 hepatocellular carcinomas 58 electrocardiographic 58 STEP BD 58 PSA kinetics 58 Repeatability 58 aneuploidy screening 58 IGRAs 58 reinfarction 58 TEAEs 58 IgA deficiency 58 transrectal ultrasound guided 58 cerebral oxygenation 58 interobserver agreement 58 aldosterone antagonist 58 preoperative chemotherapy 58 serum PTH 58 monoclonal gammopathy 58 transurethral resection 58 pharmacokinetic parameters 58 prospective cohort 58 serum calcium 58 computed tomographic 58 hepatic cirrhosis 58 MTHFD1L gene 58 UGT#A# * 58 BMI waist circumference 58 micrometastasis 58 COL#A# 58 HSCT 58 IDDM 58 hepatorenal syndrome 58 karyotype 58 Baseline characteristics 58 VT VF 58 histologic findings 58 SELENA SLEDAI 58 serum urate 58 thyroid nodules 58 T2 lesions 58 β = 58 colonoscopic 58 Endothelial dysfunction 58 systolic dysfunction 58 predictive validity 58 cTnT levels 58 RVOT 58 gastric adenocarcinoma 58 neoadjuvant 58 male Wistar rats 58 thiopurine 58 phylogenetic analyzes 58 hMG 58 HBeAg negative 58 radiochemotherapy 58 arteriography 58 State Examination MMSE 58 colorectal neoplasms 58 irbesartan 58 mCi 58 HER2 positivity 58 percutaneous biopsy 58 Y BOCS 58 LDL particle 58 virological response 58 nonnucleoside reverse transcriptase inhibitors 58 hemorrhagic complications 58 subscores 58 neurologic progression 58 pancreatectomy 58 Disease Activity 58 oocytes retrieved 58 #S rRNA 58 vesicoureteral reflux 58 microarray experiments 58 neurocognitive impairment 58 Histological 58 TRUS biopsy 58 Adjuvant therapy 58 prostate TURP 58 urine albumin 58 hemoglobin A1c levels 58 ICD implantation 58 antiangiogenic therapy 58 ictal 58 TKAs 58 fraternal twin pairs 58 Haptoglobin 58 serum markers 58 PTPN# 58 HRQOL 58 apolipoproteins 58 ischemic cardiomyopathy 58 bleomycin 58 isoprostane 58 serum homocysteine 58 serum lipid levels 58 TPV r 58 prospectively stratified 58 KRAS mutations occur 58 denervation 58 clinically meaningful improvement 58 ARB telmisartan 58 tryptophan depletion 58 detrusor overactivity 58 Lp PLA 2 58 gestational diabetes mellitus 58 urodynamic studies 58 thyroidectomy 58 ovariectomized 58 dichotomous variables 58 left ventricular LV 58 Likert 58 anterior temporal 58 leiomyomas 58 preserved ejection fraction 58 % CI #.#-#.# [001] 58 prognostic biomarker 58 empiric treatment 58 rFVIIa 58 pathologic diagnosis 58 HIV HCV coinfected 58 International Prognostic Scoring 58 hippocampal atrophy 58 CANCIDAS 58 Breslow thickness 58 preintervention 58 plasma lipid 58 cTnT 58 alanine aminotransferase ALT 58 HOXB# 58 cardiac troponin T 58 elevated IOP 58 acetabular dysplasia 58 ug dose 58 clinically meaningful reductions 58 noninferiority 58 OSAHS 58 immunosuppressive regimen 58 promoter methylation 58 silent myocardial ischemia 58 catheter ablations 58 CaPSURE 58 eplerenone 58 paricalcitol 58 APOC3 58 regression analysis 58 pulmonary angiography 58 microalbuminuria 58 mg BID dose

Back to home page